Terminology and morphologic criteria of neuroblastic tumors - Recommendations by the International Neuroblastoma Pathology Committee

被引:3
|
作者
Shimada, H
Ambros, IM
Dehner, LP
Hata, J
Joshi, VV
Roald, B
机构
[1] Childrens Hosp Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90027 USA
[2] St Anna Childrens Hosp, Childrens Canc Res Inst, A-1090 Vienna, Austria
[3] Barnes Hosp, Dept Pathol, St Louis, MO 63110 USA
[4] Keio Univ, Sch Med, Dept Pathol, Tokyo 160, Japan
[5] Hartford Hosp, Dept Pathol & Lab Med, Hartford, CT 06115 USA
[6] Ulleval Univ Hosp, Dept Pathol, Oslo, Norway
关键词
neuroblastic tumors; neuroblastoma; ganglioneuroblastoma; ganglioneuroma; Schwannian stroma; pathology; morphology; classification;
D O I
10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.3.CO;2-P
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND, As part of the international cooperative effort to develop a complete set of International Neuroblastoma Risk Groups, the International Neuroblastoma Pathology Committee (INPC) initialed activities in 1994 to devise a morphologic classification of neuroblastic tumors (NTs; neuroblastoma, ganglioneuroblastoma, and ganglioneuroma). METHODS. Six member pathologists (H.S., I.M.A., L.P.D., J.H., V.VJ., and B.R.) discussed and defined morphologically based classifications (Shimada classification; risk group and modified risk group proposed by Joshi et al.) on the basis of a review of 227 cases, using various pathologic characteristics of the NTs. The classification-grading system was evaluated for prognostic significance and biologic relevance. RESULTS. The INPC has adopted a prognostic system modeled on one proposed by Shimada et al. It is an age-linked classification dependent on the differentiation grade of the neuroblasts, their cellular turnover index, and the presence or absence of Schwannian stromal development. Based on morphologic criteria defined in this article, NTs were classified into four categories and their subtypes: 1) neuroblastoma (Schwannian stroma-poor), undifferentiated, poorly differentiated, and differentiating; 2) ganglioneuroblastoma, intermixed (Schwannian stroma-rich); 3) ganglioneuroma (Schwannian stroma-dominant), maturing and mature; and 4) ganglioneuroblastoma, nodular (composite Schwannian stroma-rich/stroma-dominant and stroma-poor). Specific features, such as the mitosis-karyorrhexis index, the mitotic rate, and calcification, were also included to allow the prognostic significance of the classification to be tested. Recommendations are made regarding the surgical materials to use for an optimal pathobiologic assessment and the practical handling of samples. CONCLUSIONS. The current article covers the essentials and important points regarding the histopathologic evaluation of NTs. Using the morphologic criteria described herein, the INPC is proposing the International Neuroblastoma Pathology Classification. It is reported in a companion article in this issue (Cancer 1999;86:363-71). Cancer 1999;86:349-63. (C) 1999 American Cancer Society.
引用
收藏
页码:349 / 363
页数:15
相关论文
共 16 条
  • [1] Peripheral neuroblastic tumors: Pathologic classification based on recommendations of International Neuroblastoma Pathology Committee (Modification of Shimada classification)
    Joshi, VV
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2000, 3 (02) : 184 - 199
  • [2] Peripheral neuroblastic tumors with genotype-phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee
    Suganuma, Rie
    Wang, Larry L.
    Sano, Hideki
    Naranjo, Arlene
    London, Wendy B.
    Seeger, Robert C.
    Hogarty, Michael D.
    Gastier-Foster, Julie M.
    Look, A. Thomas
    Park, Julie R.
    Maris, John M.
    Cohn, Susan L.
    Amann, Gabriele
    Beiske, Klaus
    Cullinane, Catherine J.
    d'Amore, Emanuele S. G.
    Gambini, Claudio
    Jarzembowski, Jason A.
    Joshi, Vijay V.
    Navarro, Samuel
    Peuchmaur, Michel
    Shimada, Hiroyuki
    PEDIATRIC BLOOD & CANCER, 2013, 60 (03) : 363 - 370
  • [3] International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors - A report from the Children's Cancer Group
    Shimada, H
    Umehara, S
    Monobe, Y
    Hachitanda, Y
    Nakagawa, A
    Goto, S
    Gerbing, RB
    Stram, DO
    Lukens, JN
    Matthay, KK
    CANCER, 2001, 92 (09) : 2451 - 2461
  • [4] Pathology of peripheral neuroblastic tumors:: Significance of prominent nucleoli in undifferentiated/poorly differentiated neuroblastoma
    Tornoczky, Tamas
    Semjen, David
    Shimada, Hiroyuki
    Ambros, Inge M.
    PATHOLOGY & ONCOLOGY RESEARCH, 2007, 13 (04) : 269 - 275
  • [5] Histopathology (international neuroblastoma pathology classification) and MYCN status in patients with peripheral neuroblastic tumors - A report from the children's cancer group
    Goto, S
    Umehara, S
    Gerbing, RB
    Stram, DO
    Brodeur, GM
    Seeger, RC
    Lukens, JN
    Matthay, DK
    Shimada, H
    CANCER, 2001, 92 (10) : 2699 - 2708
  • [6] Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification
    Koshy, Abin
    Jain, Richa
    Srinivasan, Radhika
    Bhatia, Prateek
    Kakkar, Nandita
    Rajwanshi, Arvind
    Gupta, Nalini
    Dey, Pranab
    Trehan, Amita
    Bansal, Deepak
    CYTOPATHOLOGY, 2019, 30 (06) : 634 - 643
  • [7] CD44s expression correlated with the International Neuroblastoma Pathology Classification (Shimada system) for neuroblastic tumours
    Munchar, MJJ
    Sharifah, NA
    Jamal, R
    Looi, LM
    PATHOLOGY, 2003, 35 (02) : 125 - 129
  • [8] Expressions of Somatostatin Receptor Subtypes (SSTR-1, 2, 3, 4 and 5) in Neuroblastic Tumors; Special Reference to Clinicopathological Correlations with International Neuroblastoma Pathology Classification and Outcomes
    Watanabe, Noriko
    Nakanishi, Yoko
    Kinukawa, Noriko
    Ohni, Sumie
    Obana, Yukari
    Nakazawa, Atsuko
    Nemoto, Norimichi
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2014, 47 (05) : 219 - 229
  • [9] New Morphologic Findings Support Invasiveness Criteria in Small-Sized Nonmucinous Lepidic Adenocarcinoma: Commenting a Proposal From the International Association for the Study of Lung Cancer Pathology Committee
    Visca, Paolo
    Gallo, Enzo
    Marino, Mirella
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : 387 - 389
  • [10] Recommendations from the 2012 International Society of Urological Pathology Vancouver Consensus Conference on Renal Tumors
    Ozagari, Ayse Aysim
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2015, 14 (04): : 285 - 289